Entera Bio Ltd. (NASDAQ:ENTX) Q2 2020 Results Conference Call August 20, 2020 8:30 AM ET Company Participants Jon Lieber - U.S. CFO, Entera Roger Garceau - Interim CEO Dr. Phillip Schwartz - President of R&D Arthur Santora - Chief Medical Officer Conference Call Participants Brett Hoffman - Maxim Group Operator Good morning and welcome to Entera Bio's Conference Call to discuss the Interim Six Month Results from the EB613 Phase 2 Clinical Trial and the Financial and Operating Results from the Second Quarter ...